What are the intramuscular (IM) medication options for acute psychosis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 24, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Intramuscular Medication Options for Acute Psychosis

Primary Recommendation

For acute psychotic agitation, use intramuscular olanzapine 10 mg as first-line therapy, or alternatively haloperidol 5 mg IM combined with lorazepam 2 mg IM, with olanzapine preferred due to superior tolerability and equivalent efficacy. 1, 2

First-Line IM Options

Olanzapine 10 mg IM

  • Olanzapine 10 mg IM is statistically superior to placebo and equivalent to haloperidol 7.5 mg IM for reducing agitation at 2 hours post-injection in patients with schizophrenia and bipolar mania. 2
  • Does not prolong QT interval, making it safer in patients without cardiac screening. 3
  • Produces significantly fewer extrapyramidal symptoms compared to typical antipsychotics. 4
  • Patients may receive up to 3 injections in 24 hours, with subsequent doses given at least 2 hours apart (maximum 30 mg/day). 2

Haloperidol 5 mg IM (with or without lorazepam)

  • Initial dose of 2.5-10 mg IM, with subsequent doses every 4-6 hours as needed for prompt control of acute agitation. 5, 6
  • Combination of haloperidol 5 mg plus lorazepam 2-4 mg IM produces significantly greater reduction in agitation compared to either agent alone at 1 hour. 1
  • Haloperidol monotherapy carries 20% risk of extrapyramidal side effects, which can be mitigated by combination with benzodiazepines. 1

Second-Line IM Options

Ziprasidone 10-20 mg IM

  • More effective than haloperidol IM in reducing BPRS total scores and agitation items with lower incidence of movement disorders. 7
  • AVOID in patients without cardiac history due to QT prolongation risk. 3
  • Initial dose 10 mg, with subsequent doses of 5-20 mg every 4-6 hours (maximum 80 mg/day). 7

Combination Therapy: Haloperidol + Promethazine

  • Haloperidol 10 mg plus promethazine 25-50 mg achieved equal tranquilization rates (96%) compared to lorazepam 4 mg at 4 hours. 1

Oral Alternative for Cooperative Patients

Risperidone 2 mg + Lorazepam 2 mg PO

  • Single oral dose of risperidone 2 mg plus lorazepam 2 mg is as effective as haloperidol 5 mg IM plus lorazepam 2 mg IM for rapid control of agitation, with significant improvements at 30,60, and 120 minutes. 8
  • This oral regimen is an acceptable alternative when patients are cooperative and can take oral medication. 4, 8

Critical Dosing Principles

Avoid Excessive Dosing

  • Maximum recommended dose for haloperidol in first-episode psychosis is 4-6 mg/day; higher doses increase extrapyramidal symptoms without improving efficacy. 5
  • Doses above 4-6 mg/day of typical antipsychotics do not demonstrate greater efficacy. 4

Transition to Oral Therapy

  • Switch to oral formulation within 12-24 hours following last parenteral dose once acute agitation is controlled. 6
  • Use the parenteral dose administered in preceding 24 hours as initial approximation for total daily oral dose. 6

Agents to AVOID

  • Droperidol: Associated with QT prolongation; avoid without cardiac screening. 3
  • Ziprasidone: QT prolongation risk limits use in emergency settings without ECG. 3
  • Typical antipsychotics as monotherapy in first-episode psychosis due to 50% risk of irreversible tardive dyskinesia in elderly after 2 years of continuous use. 4

Common Pitfalls

  • Changing medications before 4-6 weeks of adequate trial prevents proper efficacy assessment. 3
  • Failing to monitor for extrapyramidal side effects, which compromise future medication adherence. 5, 4
  • Using haloperidol monotherapy without benzodiazepine co-administration increases risk of acute dystonia and akathisia. 1
  • Administering repeat doses before allowing adequate time for initial dose to reach peak effect (minimum 2 hours for olanzapine IM). 2

Special Considerations

  • In elderly or debilitated patients, start with lower haloperidol doses (0.5-2.5 mg IM) and titrate more gradually. 5, 6
  • Rule out organic causes of psychosis (delirium, substance intoxication, anticholinergic toxicity) before administering antipsychotics, as these conditions may worsen with dopamine blockade. 4
  • Lorazepam 2 mg produces more rapid decrease in agitation scores at 1-3 hours compared to haloperidol 5 mg, but combination therapy is superior to either alone. 1

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Best Antipsychotic for Acute THC-Induced Psychosis Without QT Prolongation

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Management of Psychotic Features with Hallucinations

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Haloperidol Dosing Guidelines for Schizophrenia and Acute Psychosis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.